Illegal Drug Use or Not—The Role of the Laboratory in Helping to Interpret Drug Test Results
The Journal of Applied Laboratory Medicine · 2024
DOI: 10.1093/jalm/jfae008 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2024. Verfasst von Jeanne Carr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Consultant, Hattiesburg, MS 38672, United States. Hauptthemen laut MEDLINE: Substance Abuse Detection, Illicit Drugs. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
A 72-year-old female visited her pain clinic for a routine visit to obtain a refill prescription of gabapentin (300 mg, 3 times daily), which had controlled extremity radicular pain for 2 years. Other medication/supplements taken daily include rosuvastatin (20 mg), low dose aspirin, vitamin D, CoQ10, folic acid, vitamin B12, DHA, and cocoa flavonoids. Her regular physician of 5 years had left the practice; therefore, she was seeing a Physician Assistant (PA) for the first time. All vital signs were normal, and a urine drug screen was ordered according to standing protocol. Subsequently, the patient was informed that her urine drug test detected “a lot of codeine and less morphine” and that she had apparently taken nonprescribed Tylenol III. She was issued a verbal warning and informed that, if it reoccurred, she would be discharged. The patient strongly denied taking Tylenol III or any other nonprescribed medications and requested copies of both the presumptive test (performed in the clinic using a point of care drug test) and the definitive testing report from the reference laboratory. After multiple requests, the reports were received and reviewed by the patient, a retired laboratorian and former inspector for the College of American Pathologists. The reference laboratory report (Table 1) included a column labeled “Remarks” whose meaning was undefined, potentially misleading a provider to believe the patient had taken Tylenol III. Her requests to speak directly to an MD or PA about this report were denied. She was informed that her denial of taking Tylenol III would be recorded in her medical record, but review of her medical record showed her denial was not recorded. There were also several totally inaccurate statements including the diagnosis code “Long term (curr) use of opiates/Use of methadone” and that she had been counseled by the PA on the use and dangers of opiates. She had never been counseled by the PA nor ever taken opiates or methadone. The patient used the Patient Portal to request her record be corrected. The PA admitted via the portal that the diagnosis and counseling comments were templates used for all patients on a controlled substance even if the prescribed drug was not an opiate and these notations could not be removed. LC–MS/MS quantitative confirmation results. Dissatisfied, the patient continued her investigation. She reviewed everything she had eaten during the 24 hours prior to the drug test and remembered she had eaten 2 slices of avocado toast sprinkled with a seasoning blend (DASH® Everything but the Salt) for breakfast before her morning appointment. She consulted a forensic toxicologist with her questions about the reference laboratory report and the possibility that poppy seeds had caused the positive opiate result. The toxicologist contacted the Laboratory Director of the testing laboratory and learned they had not tested for acetaminophen (Tylenol) and the drugs in the “Remarks” column of their report were listed only as possible sources of the positive drug. Meanwhile the patient obtained several “at home” drug testing kits (CVS® Home Drug Test; 2000 ng/mL cutoff for opiates) and tested urine samples prior to eating the toast (0 hour) and at 2, 24, and 48 hours postingestion. The 0- and 48-hour samples tested negative while the 2- and 24-hour samples were positive for opiates. This experiment was later repeated in conjunction with a College of American Pathologists-accredited laboratory utilizing 4 volunteers and 4 lots of the seasoning blend. After ingestion, 3 lots led to positive urine results for codeine and morphine (immunoassay screening and LC–MS/MS confirmation) and as seen with the patient, codeine concentrations were higher than morphine concentrations. The original lot used by the patient was included and yielded positive results in the volunteers. Was this patient’s positive opiates result caused by ingestion of codeine or poppy seeds? What methods have laboratories used to differentiate whether ingestion of codeine or poppy seeds is the cause of a positive urinary codeine result? What is the source of the morphine? What instructions should a pain clinic provider give to a patient before they collect a urine sample for opiates screening? What are the possible outcomes for a patient testing positive for opiates? In the 1980s, studies demonstrated ingestion of food products containing poppy seeds could result in detection of morphine and codeine (1–3). When the Federal Workplace Drug Testing program was initiated in September 1986 following President Reagan’s issuance of Executive Order 12564, the immunoassay screening cutoff for opiates was 300 ng/mL but was raised to 2000 ng/mL in 1998 (4) in an attempt to decrease or eliminate positive results due to consumption of poppy seeds. A screening cutoff of 300 ng/mL is still used for clinical purposes including monitoring of pain management patients. Although poppy seeds may contain a small amount of codeine and morphine, these alkaloids are present in the opium latex (milky sap) on the seeds and can remain if the seeds are not properly washed and processed (5). In previously mentioned studies (1–3), the typical pattern observed in urine following ingestion of poppy seeds was a morphine concentration significantly higher than codeine. The criterion used to differentiate a positive result due to the intake of codeine from ingestion of poppy seeds is a positive opiates screen above 300 ng/mL and a morphine to codeine ratio of 300 ng/mL and a morphine to codeine ratio of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Consultant, Hattiesburg, MS 38672, United States.
- Encore Health Group, Spectrum Pain Clinics, Nashville, TN 37217, United States.
- Department of Medical Laboratory Sciences, LSUHSC, New Orleans, LA 70112, United States.
Zitieren
APA
Carr, J., Hurst, J., & Broussard, L. A. (2024). Illegal Drug Use or Not—The Role of the Laboratory in Helping to Interpret Drug Test Results. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfae008
Vancouver
Carr J, Hurst J, Broussard LA. Illegal Drug Use or Not—The Role of the Laboratory in Helping to Interpret Drug Test Results. The Journal of Applied Laboratory Medicine. 2024. doi:10.1093/jalm/jfae008
BibTeX
@article{Carr2024,
author = {Carr, Jeanne and Hurst, Jeffrey and Broussard, Larry A},
title = {Illegal Drug Use or Not—The Role of the Laboratory in Helping to Interpret Drug Test Results},
journal = {The Journal of Applied Laboratory Medicine},
year = {2024},
doi = {10.1093/jalm/jfae008}
}
EUVIMED